Explore the Open Market Consultation Document to learn how you can become part of our research and development journey and shape the future of TEM
IMPRESS is delighted to announce the publication of the Open Market Consultation Document. This comprehensive document outlines the objectives and rules for the Open Market Consultation (OMC) pertaining to the future Pre-Commercial Procurement (PCP) of Research and Development (R&D) services related to the IMPRESS project.
Through this OMC, the Public Buyers Group of IMPRESS PCP aims to engage technology vendors and inform them about the forthcoming PCP of R&D services. The procurement will focus on the design, development, and testing of an innovative cartridge-based interoperable platform for TEM.
The primary objectives of this OMC are as follows:
- To validate the findings of the State-Of-The-Art (SOTA) analysis and assess the viability of the technical and financial provisions.
- To raise awareness among industry and other relevant stakeholders, including users, about the upcoming PCP.
- To gather insights from the industry and relevant stakeholders, including users, to fine-tune the tender specifications.
The target audience for this OMC includes users, technology vendors, and research technology organizations. All interested parties are invited to participate in the OMC.
The OMC includes a request for information in the form of an EU Survey questionnaire. This survey will enable the IMPRESS Consortium to obtain valuable feedback from the market regarding the main challenges of the project. The survey results will be taken into account in the drafting of the IMPRESS PCP call for tenders, particularly concerning the design, prototype testing, and evaluation of the solutions.
Your participation and feedback are highly appreciated and will contribute to shaping the success of the IMPRESS project!
You may also be interested in
We are delighted to announce two upcoming information events focused on the Pre-Commercial Procurement (PCP) procedure and its potential to make you part of our research and development journey.